RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database
Identificadores
Identificadores
Data de publicación
2015Título da revista
Modern Rheumatology
Tipo de contido
Artigo